Search icon

SIMPORE INC.

Company Details

Name: SIMPORE INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Active
Date of registration: 13 Feb 2007 (18 years ago)
Entity Number: 3476551
ZIP code: 14586
County: Monroe
Place of Formation: Delaware
Address: 150 LUCIUS GORDON DRIVE, SUITE 110, WEST HENRIETTA, NY, United States, 14586

DOS Process Agent

Name Role Address
SIMPORE INC. DOS Process Agent 150 LUCIUS GORDON DRIVE, SUITE 110, WEST HENRIETTA, NY, United States, 14586

Chief Executive Officer

Name Role Address
THOMAS R GABORSKI Chief Executive Officer 150 LUCIUS GORDON DRIVE, SUITE 110, WEST HENRIETTA, NY, United States, 14586

U.S. Small Business Administration Profile

The U.S. Small Business Administration (SBA) helps Americans start, grow, and build resilient businesses.

Note: SBA was created in 1953 as an independent agency of the federal government to aid, counsel, assist and protect the interests of small business concerns; preserve free competitive enterprise; and maintain and strengthen the overall economy of our nation. SBA reviews Congressional and testifies on behalf of small businesses. It assesses the impact of regulatory burden on small businesses.

E-Commerce Website:
Phone Number:
E-mail Address:
Contact Person:
PAUL THEN
User ID:
P0853239
Trade Name:
SIMPORE INC

Commercial and government entity program

The The Commercial And Government Entity Code (CAGE) is assigned by the Department of Defense's Defense Logistics Agency (DLA) and represents your company's physical address for GSA's mailings, payments, and administrative records.

Note: A CAGE Code enables a company to contract with the U.S. government, allowing bid on government contracts and to receive government payments. Also for business this means that it's a Verified business entity and Has a validated physical address.

CAGE number:
4Q573
Status:
Active
Type:
U.S./Canada Manufacturer
CAGE Update Date:
2024-03-10
CAGE Expiration:
2028-11-21
SAM Expiration:
2024-11-16

Contact Information

POC:
JAMES ROUSSIE
Phone:
+1 585-944-3623
Fax:
+1 888-249-2935

History

Start date End date Type Value
2019-02-06 2021-02-17 Address 150 LUCIUS GORDON DRIVE, SUITE 110, WEST HENRIETTA, NY, 14586, USA (Type of address: Service of Process)
2013-02-13 2019-02-06 Address 150 LUCIUS GORDON DRIVE, SUITE 121, WEST HENRIETTA, NY, 14586, USA (Type of address: Chief Executive Officer)
2013-02-13 2019-02-06 Address 150 LUCIUS GORDON DRIVE, SUITE 121, WEST HENRIETTA, NY, 14586, USA (Type of address: Principal Executive Office)
2013-02-13 2019-02-06 Address 150 LUCIUS GORDON DRIVE, SUITE 121, WEST HENRIETTA, NY, 14586, USA (Type of address: Service of Process)
2011-02-17 2013-02-13 Address 150 LUCIUS GORDON DRIVE, SUITE 100, WEST HENRIETTA, NY, 14586, USA (Type of address: Principal Executive Office)

Filings

Filing Number Date Filed Type Effective Date
210217060225 2021-02-17 BIENNIAL STATEMENT 2021-02-01
190206060275 2019-02-06 BIENNIAL STATEMENT 2019-02-01
170213006124 2017-02-13 BIENNIAL STATEMENT 2017-02-01
150205006088 2015-02-05 BIENNIAL STATEMENT 2015-02-01
130213006247 2013-02-13 BIENNIAL STATEMENT 2013-02-01

USAspending Awards / Financial Assistance

Date:
2022-02-25
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
COMMERCIALIZING THE ?SIM: A MODULAR PLATFORM FOR THE DEVELOPMENT AND ANALYSIS OF BARRIER TISSUE MODELS - ABSTRACT THIS PROJECT WILL COMMERCIALIZE A CELL CULTURE PLATFORM FEATURING SIMPORE'S ULTRATHIN SILICON- BASED MEMBRANE TECHNOLOGY TO ENABLE ADVANCED RESEARCH ON TISSUE BARRIERS. IN VITRO MODELS OF TISSUE BARRIERS SUCH AS THE GUT, LUNG, AND VASCULATURE ARE IMPORTANT FOR UNDERSTANDING THE BASIS OF DISEASE AND FOR ASSESSING THE ABILITY OF DRUG FORMULATIONS TO REACH TARGET TISSUES. DESPITE THE GROWING USE OF SOPHISTICATED CELL CULTURE PLATFORMS (E.G., 3D CELL CULTURE, MICROPHYSIOLOGICAL SYSTEMS, AND TISSUE CHIPS), THE SIMPLEST AND MOST POPULAR TOOLS FOR THE IN VITRO STUDY OF BARRIER TISSUES REMAINS THE CORNING TRANSWELL™ AND ITS COMPETITORS (COLLECTIVELY REFERRED TO HEREIN AS “TRANSWELLS™”). THESE PRODUCTS HAVE A SUSPENDED ~ 10 ΜM THICK POLYMER MEMBRANE CREATING APICAL AND BASAL COMPARTMENTS WHICH SEPARATE MONO- OR CO-CULTURES GROWN ON THE MEMBRANES. DESPITE THEIR POPULARITY, TRANSWELLS® DO NOT SUPPORT HIGH RESOLUTION MICROSCOPY NOR PROVIDE THE UID OW NEEDED TO PROPERLY STUDY VASCULAR BARRIERS AND IMMUNE CELL TRACKING. SIMPORE'S MEMBRANES WILL BE COMMERCIALIZED AS CELL CULTURE PRODUCTS THAT OVERCOME LIMITATIONS OF TRANSWELLS®, WHILE RETAINING THEIR EASY TO USE FORMAT AND OERING FEATURES FOUND IN MORE SOPHISTICATED TISSUE CHIPS. OUR PHASE I PROJECT SUCCESSFULLY TRANSLATED THE LABORIOUS HAND-MADE DEVICES USED IN THE LABORATORY OF PROFESSOR JAMES MCGRATH (UNIVERSITY OF ROCHESTER) TO A SCALABLE FABRICATION WORKOW AT SIMPORE. USING A MODULAR DESIGN, WE DEVELOPED AN OPEN-WELL TRANSWELL-STYLE CULTURE UNIT THAT INCORPORATES SIMPORE'S MEMBRANES, WHICH FURTHER CONVERTS TO A OW CELL WITH THE ADDITION OF A PLUG-AND-PLAY OW MODULE. DEVICES WERE DISTRIBUTED TO NINE COLLABORATING LABORATORIES, ALL OF WHOM REPORTED SUCCESS WITH THE PLATFORM. SIMPORE ALSO SUCCESSFULLY TRANSLATED THE DUAL-SCALE MICRO/NANOPOROUS MEMBRANES DEVELOPED BY THE MCGRATH LABORATORY TO WAFER-SCALE MANUFACTURING. OUR PHASE II PROJECT WILL CREATE COMMERCIALLY VIABLE VERSIONS OF PHASE I PROTOTYPES TO BE MARKETED UNDER THE CYTOVU™ BRAND. AIM 1 WILL INCREASE MEMBRANE MANUFACTURING CAPACITY BY RELIEVING PRODUCTION BOTTLENECKS AND INTEGRATING AUTOMATION. AIM 2 FOCUSES ON AUTOMATING CYTOVU™ DEVICE ASSEMBLY. AIM 3 WILL TEST THE MANUFACTURED DEVICES IN A NETWORK OF COLLABORATING LABORATORIES WHILE DEVELOPING ACCESSORIES THAT MAKE THE PLATFORM INCREASINGLY VERSATILE AND EASY TO USE. THIS PROJECT WILL ESTABLISH SCALABLE MANUFACTURING CAPACITY AT SIMPORE FOR THE CYTOVU™ AND ITS ACCESSORIES, AND ALSO VALIDATE CYTOVU™ PRODUCTS AS COMPETITIVE ALTERNATIVES TO INCUMBENT PRODUCTS FOR THE IN VITRO STUDY OF BARRIER TISSUES.
Obligated Amount:
1694475.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2021-08-09
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
COMMERCIALIZATION OF NOVEL SILICON MICROSLIT FILTERS FOR MICROPLASTIC CONTAMINATION TESTING - ABSTRACT ENVIRONMENTAL POLLUTION BY MICROPLASTICS (MPS) IN FRESH WATER AND OCEANS IS A GROWING PROBLEM THAT IS NOW WELL-RECOGNIZED IN BOTH THE POPULAR MEDIA AND SCIENTIFIC LITERATURE. CONCERNING LEVELS OF MPS HAVE BEEN FOUND IN FOOD AND LOCAL WATERS, AS WELL AS IN HUMAN TISSUES. SEVERAL GOVERNMENT REGULATORY BODIES HAVE (OR ARE IN THE PROCESS OF) IMPLEMENTING MANDATORY MP DRINKING WATER TESTING, INCLUDING THE STATE OF CALIFORNIA, CANADA, AND A NUMBER OF EU COUNTRIES. THIS PHASE II SBIR PROJECT ADDRESSES THE NEED FOR IMPROVED TOOLS AND RELATED SERVICES FOR CAPTURING AND ANALYZING MPS. OUR PRECEDENT PHASE I SBIR AWARD ESTABLISHED THE UTILITY OF OUR (SIMPORE'S) SILICON NANOMEMBRANES WITH MICRON-SCALE RECTANGULAR PORES (“MICROSLIT FILTERS”) FOR THE CAPTURE AND ANALYSIS OF MPS. WE DEMONSTRATED UTILITY IN DETECTING MPS IN CONSUMER BEVERAGES AND THROUGHOUT A SPATIAL MAP OF THE CITY OF ROCHESTER (NY) WATER SYSTEM. WE CREATED A NEW VENTURE (PARVERIO) COMMERCIALIZING MP TESTING SERVICES BASED ON SIMPORE'S MEMBRANES. WE ESTABLISHED PRODUCTS' FEATURES ACCORDING TO VOICE-OF-CUSTOMER DATA, ARE PARTICIPATING IN AN INTERNATIONAL MP DETECTION LAB VALIDATION STUDY, AND ARE ENGAGING A LARGE INSTRUMENT VENDOR AS CO-DEVELOPMENT PARTNER FOR PRODUCT MARKETING. THIS PHASE II PROJECT WILL ADVANCE THE MANUFACTURING OF MICROSLIT FILTERS, AUTOMATE THEIR PACKAGING INTO 13 MM DISCS FOR COMPATIBILITY WITH EXISTING VACUUM FILTRATION DEVICES, AND DEVELOP PERIPHERALS FOR RAPID MP SCREENING AND FILTER ANALYSIS. WE WILL SCALE OUR NANOMEMBRANE PRODUCTION TO MULTI-WAFER BATCHES TO REACH COST-OF-GOOD TARGETS IN LINED WITH IDENTIFIED PRICING LEVELS. WE WILL DEVELOP A PROCESS FOR COMBINING INJECTION-MOLDED 13 MM DISC BLANKS AND NANOMEMBRANE CHIPS USING PICK-AND-PLACE ROBOTICS, PRECISION GLUEING, AND THERMAL CURING. WE WILL ALSO DEVELOP TWO PERIPHERAL PRODUCTS: 1) A MACHINED 25X75 MM FOOTPRINT MICROSCOPE SLIDE TO HOLD THREE 13 MM DISCS; AND 2) A PROPRIETARY FILTRATION APPARATUS WITH SOFTWARE, READOUTS, AND TRANSMEMBRANE PRESSURE SENSORS FOR RAPID WATER SAMPLE SCREENING. THIS SECOND DEVICE WILL AUTOMATE THE IDENTIFICATION OF SAMPLES WITH DEBRIS AND THE PRODUCTION OF OPTIMAL SAMPLES FOR ANALYSIS. THROUGH SUBCONTRACTS, WE WILL SUPPORT NOVEL END-USE APPLICATIONS AT SPIN-OUT PARVERIO AND THE UNIVERSITY OF ROCHESTER (UR). PARVERIO WILL DEVELOP A MP CHALLENGE TEST (NSF/ANSI 42 PARTICULATE CLASS I REDUCTION STANDARD) AS A SERVICE FOR ASSESSING MP REMOVAL EFFICIENCY OF FILTRATION PRODUCTS. AT UR, THE MCGRATH AND KNOX LABS WILL DEVELOP THERMAL BIREFRINGENCE USING MICROSLIT FILTERS AS A LOW-COST, LABEL FREE APPROACH FOR MP IDENTIFICATION. THE SUCCESSFUL DEVELOPMENT OF THERMAL BIREFRINGENCE WOULD BECOME A PARVERIO SERVICE AND PRODUCT AND DRAMATICALLY EXPAND THE NUMBER OF END-USERS DOING MP ANALYSIS BECAUSE OF LOW INSTRUMENT COSTS. THIS PHASE II PROJECT WILL SUPPORT THE COMMERCIALIZATION OF SIMPORE'S MICROSLIT FILTERS TO MEET THE EXPANDING NEEDS FOR MP CAPTURE AND ANALYSIS PRODUCTS AND RELATED SERVICES. OUR PRODUCTS WILL BENEFIT A GROWING NUMBER OF CONCERNED WATER AUTHORITIES, REGULATORY BODIES, AND RESEARCHERS WORKING TO UNDERSTAND THE SCOPE OF MP POLLUTION AND TO MITIGATE ITS IMPACTS ON HEALTH AND THE ENVIRONMENT.
Obligated Amount:
1371081.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2021-01-29
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
62410.00
Total Face Value Of Loan:
62410.00
Date:
2020-05-06
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
COMMERCIALIZING THE ?SIM: A MODULAR PLATFORM FOR THE DEVELOPMENT AND ANALYSIS OF BARRIER TISSUE MODELS
Obligated Amount:
235000.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2020-04-13
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
72162.00
Total Face Value Of Loan:
72162.00

Trademarks Section

Serial Number:
85234570
Mark:
CYTOVU
Status:
CANCELLED - SECTION 8
Mark Type:
TRADEMARK
Application Filing Date:
2011-02-04
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
CYTOVU

Goods And Services

For:
Laboratory filters, namely, porous nanocrystalline silicon membranes for the ultrafiltration of biological molecules, particles and fluids, the filtration of small organic and inorganic molecules and particles, and the filtration of liquids and gases; and laboratory filters, namely, porous nanocryst...
First Use:
2011-01-27
International Classes:
009 - Primary Class
Class Status:
Sec. 8 – Entire Registration
Serial Number:
77211646
Mark:
ULTRASM
Status:
CANCELLED - SECTION 8
Mark Type:
TRADEMARK
Application Filing Date:
2007-06-21
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
ULTRASM

Goods And Services

For:
Laboratory filters, namely, porous nanocrystalline silicon membranes for the ultrafiltration of biological molecules, particles and fluids, the filtration of small organic and inorganic molecules and particles, and the filtration of liquids and gases; and laboratory filters, namely, porous nanocryst...
First Use:
2008-12-08
International Classes:
009 - Primary Class
Class Status:
Sec. 8 – Entire Registration
Serial Number:
99164343
Status:
New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information.
Mark Type:
Trademark, Service Mark
Application Filing Date:
2025-04-30
Mark Drawing Type:
0 - UNKNOWN MARK DRAWING TYPE
Mark Literal Elements:
None

Goods And Services

For:
Ultrathin, highly porous, optically transparent silicon nanomembranes for cell culture and imaging, fluidic filtering, and electron microscopy viewing for biomedical and material science research and analysis applications
First Use:
2022-05-25
International Classes:
009 - Primary Class
Class Status:
ACTIVE
For:
Custom fabrication of ultrathin silicon nanomembranes, genomic and photonic biosensors, and microfluid cell cultures; services related to the separation and analysis of particles by spectroscopic, optical, electron, and x-ray microscopy
First Use:
2022-05-25
International Classes:
040 - Primary Class
Class Status:
ACTIVE
Serial Number:
99164315
Mark:
SIMPORE
Status:
New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information.
Mark Type:
Trademark, Service Mark
Application Filing Date:
2025-04-30
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
SIMPORE

Goods And Services

For:
Ultrathin, highly porous, optically transparent silicon nanomembranes for cell culture and imaging, fluidic filtering, and electron microscopy viewing for biomedical and material science research and analysis applications
First Use:
2022-05-25
International Classes:
009 - Primary Class
Class Status:
ACTIVE
For:
Custom fabrication of ultrathin silicon nanomembranes, genomic and photonic biosensors, and microfluid cell cultures; services related to the separation and analysis of particles by spectroscopic, optical, electron, and x-ray microscopy
First Use:
2022-05-25
International Classes:
040 - Primary Class
Class Status:
ACTIVE
Serial Number:
88634344
Mark:
NANOBARRIER
Status:
Registered. The registration date is used to determine when post-registration maintenance documents are due.
Mark Type:
Trademark
Application Filing Date:
2019-09-27
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
NANOBARRIER

Goods And Services

For:
nanoporous silicon nitride membranes used as permeable substrates for science and research industries
First Use:
2020-04-13
International Classes:
009 - Primary Class
Class Status:
ACTIVE

Paycheck Protection Program

Date Approved:
2020-04-13
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Initial Approval Amount:
72162
Current Approval Amount:
72162
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Unanswered
Veteran:
Unanswered
Forgiveness Amount:
73041.78
Date Approved:
2021-01-29
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Initial Approval Amount:
62410
Current Approval Amount:
62410
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Unanswered
Veteran:
Unanswered
Forgiveness Amount:
63107.62

Date of last update: 28 Mar 2025

Sources: New York Secretary of State